How Biosimilars Could Impact Clinical Trials

Posted by: DaVita Clinical Research

Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more

Kidney & Renal Failure Research

Posted by: DaVita Clinical Research

Getting people with Chronic Kidney Disease (CKD) in on the ground floor. At DaVita Clinical Research, our specialty is performing research in people with chronic kidney disease (CKD). From the… Read more

Considerations When Using Adaptive Trial Design

Posted by: DaVita Clinical Research

Let’s talk adaptive trial design, particularly as it pertains to early clinical research right now.  Both large and small pharmaceutical companies see the potential to shorten development timelines using adaptive… Read more